Blood cancer research may lead to new treatments

At this year’s American Society of Hematology Annual Meeting, Dana-Farber scientists presented major findings that could one day improve diagnosis and treatment of blood cancers, extend life, or even cure some diseases.

Among the highlights:

Steven Treon, MD, PhD, and his colleagues identified a gene mutation that underlies the vast majority of cases of Waldenström’s macroglobulinemia, a rare form of non-Hodgkin lymphoma. The results suggest that new, effective treatments are now possible for people with Waldenström’s. Read more about Dr. Treon’s Waldenström’s macroglobulinemia research breakthrough.

Catherine J. Wu, MD, co-led investigators who discovered nine new gene mutations that could help doctors predict if and how chronic lymphocytic leukemia (CLL) will progress, and lead to new treatments for CLL. Take a closer look at Dr. Wu’s CLL research.

Corey Cutler, MD, MPH, and his colleagues reported on a new clinical trial that may improve the ability of stem cells from umbilical cord blood to take root in patients receiving a stem cell transplant more quickly and with a higher degree of success. Learn more about Dr. Cutler’s stem cell transplant clinical trial.

Make An Appointment

For adults: 877-960-1562

Quick access: Appointments as soon as the next day for new adult patients

For children: 888-733-4662

Latest Tweets

Dana-Farber @danafarber
Planning to get outside this weekend? Keep your skin safe and help protect yourself from skin cancer with these six… https://t.co/1iZpCNsA5x
Dana-Farber @danafarber
How does #cancer start? In general, how is it treated? Here's what you need to know: https://t.co/qx9nCPKraA https://t.co/EQbHVW2Nu5
Dana-Farber @danafarber
Two years after being given six months to live, Michael Mullan’s cancer is still at bay because of #immunotherapy a… https://t.co/uLwLoJbywq

Patient and Family Blogs

Patients and families of patients at Dana-Farber often chronicle their own experiences with cancer.

Here are some blogs that you can follow.